The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma.

M G Borrello; L Alberti; E Arighi; I Bongarzone; C Battistini; A Bardelli; B Pasini; C Piutti; M G Rizzetti; P Mondellini

doi:10.1128/MCB.16.5.2151

The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma.

Identifier:nobleid.org/w1/20260515/CF5B7979

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CF5B7979.svg?ark=w1%2F20260515%2FCF5B7979)](https://nobleid.org/work/w1/20260515/CF5B7979)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma.

Identifier:nobleid.org/w1/20260515/CF5B7979

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CF5B7979.svg?ark=w1%2F20260515%2FCF5B7979)](https://nobleid.org/work/w1/20260515/CF5B7979)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work